12 September - 15 September 2027
Organised by:
SCI’s Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector
Churchill College, Cambridge, UK
This conference will be of interest to both academic and industrial scientists engaged in all aspects of the drug discovery and development process.
The separate workshop will be of interest to early career scientists, typically with five years or fewer post-graduate experience in medicinal chemistry.
Toward pandemic-ready oral antivirals: Discovery of GS-1701,
a non-boosted pan-beta-coronavirus Mpro inhibitor
Stephen Ammann, Gliead, USA.
Discovery of AZD4956, a potent and selective inhibitor of DNA polymerase theta, a clinical
candidate for treatment of HRR-deficient tumors in combination with saruparib
Bernard Barlaam, AstraZeneca, UK
AMR Drug Discovery at the Holistic Drug Discovery and Development Centre
(H3D) at the University of Cape Town - An Overview and Future Perspectives
Grant Boyle, H3D, Republic of South Africa
Discovery of the Brain Penetrant NLRP3 inhibitor RG6434
Stefanie Mesch, Roche, Switzerland
Discovery and development of Setidegrasib (ASP3082), a first-in-class
KRAS G12D degrader for solid tumors
Takanori Koike, Astellas, Japan
Controlling Biological State with Small Molecules
Angela Russell, University of Oxford, UK
The discovery of novel orally bioavailable NS2BNS3 dengue inhibitors
Ed Griffen, MedChemica, UK
From fragment to lead: the discovery of novel, selective, small molecule inhibitors of Bfl-1
Arnaud Le Tiran, a, France
DNA Damage Response Inhibitor Mono and Dual Payload Antibody-Drug Conjugates
Robert Heald, Artios, UK
UK DDU384: From Hit Identification to a new Preclinical Candidate for Tuberculosis
Laura Cleghorn, Drug Discovery Unit, University of Dundee, UK
Optimisation of an Oral CNS Penetrant TRPM3 Inhibitor:
From HTS to an in vivo Capable Tool Compound
Alex Preston, GSK, UK
The programme will be announced in due course.
The exhibition will run alongside the conference during refreshment breaks and poster sessions. Those who wish to exhibit are encouraged to book early to avoid disappointment. Exhibition rate will include two stand staff and daytime refreshments.
For further details, please contact conferences@soci.org
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
Churchill College
Storey's Way
Cambridge
CB3 0DS
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org